SCHEMBL18285754

SCHEMBL18285754

NC1(c2ccnc([N+](=O)[O-])c2)CCCCN1C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.33
SMN1; SMN2 Q16637 5/20 0.33
MAPT P10636 4/20 0.33
S1PR1 P21453 1/20 0.32
PKM P14618 2/20 0.32
HTT P42858 3/20 0.31
POLB P06746 2/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
MCL1 Q07820 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
GAA P10253 1/20 0.30
KMT2A Q03164 2/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18285758 1.00 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2MAPTS1PR1PKM
SCHEMBL21683027 0.78 HSD11B1 (0.41) ALDH1A1SMN1; SMN2LMNACYP1A2CYP2C9
SCHEMBL1078194 0.75 RAF1 (0.40) ALDH1A1SMN1; SMN2MAPTHTTPOLB
SCHEMBL21683014 0.74 HSD11B1 (0.39) ALDH1A1SMN1; SMN2LMNACYP1A2CYP2C9
SCHEMBL3393922 0.73 MEN1 (0.47) ALDH1A1SMN1; SMN2LMNAGAAKMT2A
SCHEMBL1078190 0.71 EPHX2 (0.34) ALDH1A1SMN1; SMN2MAPTHTTPOLB
SCHEMBL29884115 0.69 GRIN1 (0.48) ALDH1A1HTTL3MBTL1KDM4EKMT2A
SCHEMBL3391147 0.69 HSD11B1 (0.44) ALDH1A1SMN1; SMN2PKMLMNAKMT2A
SCHEMBL6071816 0.68 NQO1 (0.37) ALDH1A1MAPTLMNAKDM4EBLM
SCHEMBL21683080 0.67 HIF1A (0.35) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303334-A1 TYROSINE KINASE INHIBITORS Principia Biopharma Inc. (US) 2018-04-11 EP disclosed
WO-2016196840-A1 TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2016-12-08 WO disclosed